DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Wenzel RG, Tepper S, Korab WE, Freitag F.
Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?
Ann Pharmacother 2008; 42(11): 1692-1696
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.